作者
Alessandro C Pasqualotto, Melissa O Xavier, Letícia B Sánchez, Clarice DA de Oliveira Costa, Sadi M Schio, Spencer M Camargo, Jose J Camargo, Teresa CT Sukiennik, Luiz Carlos Severo
发表日期
2010/8/15
期刊
Transplantation
卷号
90
期号
3
页码范围
306-311
出版商
LWW
简介
Background.
Galactomannan (GM) detection in serum samples has been used to diagnose invasive aspergillosis (IA). Limited sensitivity has been observed in lung transplant recipients, for whom bronchoalveolar lavage (BAL) testing has been advocated. Because airway colonization with Aspergillus species occurs frequently in these patients, false-positive GM results have been reported if the cutoff validated for sera is used (ie, 0.5).
Methods.
Herein, we prospectively studied BAL fluid samples from 60 lung transplant patients to determine the optimal cutoff for BAL GM testing. Only one sample per patient was studied. BAL samples were vortexed and processed according to the manufacturer's instructions for serum samples. Sensitivity, specificity, and likelihood ratios were calculated in reference to proven or probable IA cases using receiver operating characteristic analysis.
Results.
Eight patients had IA during the …
引用总数
2010201120122013201420152016201720182019202020212022202320241119799736932522